Author:
Matsumura Jon S.,Kim Roger,Shively Vera P.,MacDonald Robert C.,Pearce William H.
Reference24 articles.
1. The PREVENT trial of vein graft genetic engineering: preliminary molecular and clinical findings;Mann;Circulation,1998
2. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product;Chang;Science,1995
3. Moawad, J., Schwartz, L., Gewertz, B. L., Chang, M. W., and Leiden, J. M.Efficiency of adenoviral-mediated gene transfer in experimental vein grafts. Program Book, 21st Annual Meeting Midwestern Vascular Surgery Society, 1997. Pp. 30–31.
4. Improved retroviral transduction efficiency of vascular cells in vitro and in vivo during clinically relevant incubation periods using centrifugation to increase viral titers;Zelenock;J. Vasc. Surg.,1997
5. Seeding of intravascular stents with genetically engineered endothelial cells;Dichek;Circulation,1989